Platelet-rich Plasma, Corticosteroid, or Lidocaine for Acromioclavicular Joint Pain
Status:
Not yet recruiting
Trial end date:
2024-05-01
Target enrollment:
Participant gender:
Summary
This study will compare three different treatment injections for the management of
acromioclavicular joint dysfunction (ACJ Dysfunction). Patients that consent and enroll will
be randomized to receive (1) a corticosteroid injection, (2) an injection of Platelet Rich
Plasma, or (3) a Lidocaine injection. Follow-up will occur over a 1 year period.
Phase:
Phase 4
Details
Lead Sponsor:
Brooke Army Medical Center
Collaborators:
Madigan Army Medical Center The Geneva Foundation Uniformed Services University of the Health Sciences